Page last updated: 2024-08-16

piracetam and atomoxetine hydrochloride

piracetam has been researched along with atomoxetine hydrochloride in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Suvorinova, NIu; Zavadenko, NN1
Khaletskaia, OV; Lar'kina, EV1

Trials

2 trial(s) available for piracetam and atomoxetine hydrochloride

ArticleYear
[Atomoxetine and piracetam in the treatment of attention deficit hyperactivity disorder in children].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2008, Volume: 108, Issue:7

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Drug Administration Schedule; Female; Humans; Male; Nootropic Agents; Piracetam; Propylamines

2008
[Tactics of management of preschool children with different variants of speech delay].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2014, Volume: 114, Issue:12

    Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Child; Child, Preschool; Female; Humans; Intercellular Signaling Peptides and Proteins; Language Development Disorders; Male; Nootropic Agents; Peptides; Piracetam; Propylamines; Speech Disorders; Treatment Outcome

2014

Other Studies

1 other study(ies) available for piracetam and atomoxetine hydrochloride

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013